Target intelligence / Profile preview

Kidney deficiency

Molecular classification
Other
01

Overview

"Kidney deficiency" is not a scientific or canonical molecular target. The term is used colloquially, especially in non-technical contexts, to denote reduced kidney function. In medical science, the appropriate terms are "chronic kidney disease" (CKD) or "renal insufficiency," which refer to a progressive loss of kidney function. Neither "kidney deficiency" nor its variants represent a single molecule, receptor, enzyme, or other druggable target, but rather a disease state resulting from damage to multiple renal components, including nephrons, glomeruli, or renal vasculature. Treatment of CKD addresses underlying causes (such as diabetes or hypertension), symptomatic management, and renal replacement therapy at end-stage. In summary, "kidney deficiency" is not a molecular entity or valid drug target. It is a descriptive term for kidney dysfunction. The canonical terms for the pathophysiological state described are "chronic kidney disease" or "renal insufficiency."

Other names
Kidney diseaseRenal deficiencyChronic kidney disease (CKD)Renal insufficiencyKidney failureRenal failure
02

Biological functions

Other
03

Disease associations

Other
04

Safety considerations

This is not a molecular target; therefore, there are no target-specific safety concerns.However, kidney disease carries treatment challenges such as progression to end-stage renal disease, cardiovascular complications, electrolyte imbalances, anemia, and increased susceptibility to infections.
05

Biomarkers

Estimated glomerular filtration rate (eGFR)Urinary albumin-creatinine ratio (ACR)Serum creatinineBlood urea nitrogen (BUN)Urinalysis

Beyond the preview

Go deeper on Kidney deficiency.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kidney deficiency.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call